Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

BIOC
Biocept Inc
stock NASDAQ

At Close
5/30/2023 3:59:30 PM EDT
2.16USD0.000%(0.00)0
1.69Bid   2.66Ask   0.97Spread IEX
Pre-market
5/30/2023 9:21:30 AM EDT
2.15USD-0.463%(-0.01)200
After-hours
5/30/2023 4:33:30 PM EDT
2.26USD+4.630%(+0.10)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
3.174M
CEO
Michael Nall
Headquarters
San Diego, California, USA
Industry
Diagnostics & Research
Next Earnings
2023-08-14 (75d)
Last Split
2023-05-171for30reverse
BIOC Stats
Avg. Vol. 10 Day
1,035,597
Avg. Vol. 30 Day
395,720
Employees
50
Market Cap
3,173,861
Shares Out.
1,469,380
On/Off Exchange
49%/51%
6 Month Beta
1.31
1 Year Beta
0.77
2 Year Beta
0.90
3 Year Beta
0.94
52 Week Low
0.21
52 Week High
13.43
SMA50
1.18
SMA200
0.71
1 Week
-49.18%
1 Month
-71.85%
3 Month
-85.37%
6 Month
-90.54%
1 Year
-94.93%
2 Year
-98.36%
5 Year
-99.89%
Jan 21, 2022
08:03AM EST  Biocept Highlights Co. Has Received 40K+ Samples For COVID-19 Testing Since Beginning Of 2022   Benzinga
Jan 4, 2022
08:00AM EST  Biocept to Present at the H.C. Wainwright BioConnect Virtual Conference on January 10   Business Wire
Dec 9, 2021
09:47PM EST  Biocept's CNSide Cerebrospinal Fluid Assay Identifies Actionable HER2 Mutations In Patients With Breast Cancer That Has Metastasized To The Brain   Benzinga
Dec 1, 2021
08:49AM EST  Quest Diagnostics Now Offers Biocept's Liquid Biopsy Test For Lung Cancer   Benzinga
Nov 22, 2021
01:57PM EST  Biotechnologies; Test Quantifies Viral Load to Determine Infection Level and Disease Progression   PR Newswire
More News
Profile
Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers, including metastatic tumors involving lung, breast and the central nervous system. Biocept's patented Target Selectorâ„¢ technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) with higher sensitivity and specificity than most commercial assays. Additionally, Biocept is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 PCR testing to support public health efforts during this unprecedented pandemic.

BIOC Stock Summary

Biocept Inc (NASDAQ:BIOC) stock price today is $2.16, and today's volume is 0. BIOC is down 0.000% today. The 30 day average volume is 395,720. BIOC market cap is 3.174M with 1,469,380 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC